Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The current study investigates Welchol as monotherapy to improve glycemic control in subjects
with Type 2 Diabetes Mellitus not adequately controlled with diet and exercise alone. The
study will evaluate if Welchol monotherapy for Type 2 Diabetes Mellitus will be safe, well
tolerated and efficacious.